Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/1995
04/05/1995EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE
04/05/1995EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use
04/05/1995EP0646131A1 Serum amyloid a protein
04/05/1995EP0646130A1 Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides.
04/05/1995EP0646129A1 Receptor-type tyrosine kinase-like molecules
04/05/1995EP0646128A1 Glucagon-like peptide and insulinotropin derivatives
04/05/1995EP0646127A1 Polypeptide bombesin antagonists
04/05/1995EP0646022A1 Prosthetic devices having enhanced osteogenic properties
04/05/1995EP0646017A1 Immune suppressive product
04/05/1995EP0646016A1 Synthetic peptides for the treatment of myasthenia gravis
04/05/1995EP0646014A1 The use of hyperimmune milk to increase longevity
04/05/1995EP0646013A1 Platelet derived growth factor antagonists
04/05/1995EP0646012A1 Wound healing and treatment of fibrotic disorders
04/05/1995EP0646010A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression
04/05/1995EP0646000A1 Compositions using microencapsulated neutralizing antibodies
04/05/1995EP0645997A1 Cosmetic containing phospholipids and fluorocarbon compounds.
04/05/1995EP0593639B1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same
04/05/1995EP0559756B1 Nonapeptide bombesin antagonists
04/05/1995EP0469084B1 Hepatospecific insulin analogues
04/05/1995EP0422198B1 Phosphorylated plasminogen activators
04/05/1995EP0365598B1 Therapeutic antimicrobial polypeptides, their use and methods for preparation
04/05/1995EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides
04/04/1995USH1427 Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
04/04/1995US5403924 Taga gene and methods for detecting predisposition to peptic ulceration
04/04/1995US5403919 Monoclonal antibodies as inhibitors
04/04/1995US5403914 Biological mediators of immune functions
04/04/1995US5403856 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors
04/04/1995US5403833 Methods of inhibiting transplant rejecton in mammals using rapamycin and derivatives and prodrugs thereof
04/04/1995US5403826 Nutritional product for persons infected with human immunodeficiency virus
04/04/1995US5403825 Obtaining mammalian bone extract, treating with water to obtain aqueous extract, treating with alcohol to precipitate, treating with water and fractionating
04/04/1995US5403824 Administering a opioid, opioid-degrading enzyme inhibitor or enkephalin secretagogues or mixtures thereof; side effect reduction
04/04/1995US5403734 t-PA with growth factor domain substitutions
04/04/1995US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol
04/04/1995US5403725 Human T-cell hybridomas are incubated in medium of phorbol myristate acetate and/or concanavalin A, fractionated by sucrose density gradient centrifugation
04/04/1995US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label
04/04/1995US5403596 Anticoagulant from saliva of leech; does not inhibit thrombin
04/04/1995US5403586 LHRH-TraTp fusion proteins
04/04/1995US5403484 Viruses expressing chimeric binding proteins
04/04/1995CA1335083C Fr901228 substance and preparation thereof
04/04/1995CA1335079C Preventive and curative agents for acquired immune deficiency syndrome (aids)
04/04/1995CA1335077C Process for the manufacture of apolipoproteins from human blood plasma or serum
04/04/1995CA1335076C Pharmaceutical composition and method for intranasal administration
04/04/1995CA1335075C Method of inhibiting platelet dependent arterial thrombosis
04/03/1995EP0672152A4 Fusion proteins comprising mgf and il-3.
04/02/1995CA2113218A1 Method of using lectins for contraception and prophylaxis against diseases transmittable by sexual contact and apparatus for administering lectins
03/1995
03/31/1995CA2132937A1 Protein expression system
03/30/1995WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/30/1995WO1995008630A1 Surface loop structural analogues of fibroblast growth factors
03/30/1995WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995WO1995008628A2 Nucleic acids encoding merosin, merosin fragments and uses thereof
03/30/1995WO1995008624A1 HUMAN PHOSPHOLIPASE C-α AND DNA SEQUENCE CODING FOR THE SAME
03/30/1995WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995WO1995008577A1 Retargeting antibodies
03/30/1995WO1995008575A1 Monoclonal antibodies specific for feline infectious peritonitis virus
03/30/1995WO1995008574A1 Displacement chromatography process and purified hemoglobin product
03/30/1995WO1995008573A1 Peptide having antithrombotic activity and process for producing the same
03/30/1995WO1995008572A1 Interaction of t-cell receptors and antigen in autoimmune disease
03/30/1995WO1995008570A1 Chimeric proteins which block complement activation
03/30/1995WO1995008569A1 NOVEL PROTEIN sp38 AND CONTRACEPTIVE VACCINE
03/30/1995WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995WO1995008566A1 Novel peptide
03/30/1995WO1995008565A1 Use of angiotensin ii analogs in tissue repair
03/30/1995WO1995008564A1 PEPTIDE DERIVATIVES OF α-MSH AND THEIR APPLICATION
03/30/1995WO1995008563A1 Glutathione analogs and paralog panels comprising glutathione mimics
03/30/1995WO1995008560A1 Novel peptides useful for inhibiting binding of lipopolysaccharides (lps) by lipopolysaccharide binding protein (lbp)
03/30/1995WO1995008554A1 Nf-at polypeptides and polynucleotides
03/30/1995WO1995008536A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
03/30/1995WO1995008355A1 Methods for enhancing vascularization of implant devices
03/30/1995WO1995008350A1 REGULATION OF bcl-2 GENE EXPRESSION
03/30/1995WO1995008347A1 Methods and products for controlling immune responses in mammals
03/30/1995WO1995008345A1 Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid
03/30/1995WO1995008344A1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
03/30/1995WO1995008343A1 Modified truncated complement system regulators
03/30/1995WO1995008342A1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols
03/30/1995WO1995008341A1 Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
03/30/1995WO1995008340A1 Method for treating psoriasis
03/30/1995WO1995008339A1 Treatment or prevention of crohn's disease and/or ulcerative colitis
03/30/1995WO1995008338A1 Method for the treatment or prevention of eczema/dermatitis
03/30/1995WO1995008337A1 Use of angiotensin iii and analogs thereof in tissue repair
03/30/1995WO1995008336A1 Graves' ophthalmopathy associated antibodies, graves' ophthalmopathy orbital antigen, and methods of use thereof
03/30/1995WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
03/30/1995WO1995003822A3 Use of relaxin as therapeutic or preventing agent
03/30/1995WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
03/30/1995WO1994024279A3 Agents for the prevention and treatment of huntington's disease and other neurological disorders
03/30/1995DE4332985A1 Pharmaceutical composition for the treatment of exocrine pancreas dysfunction
03/30/1995CA2172610A1 Chimeric proteins which block complement activation
03/30/1995CA2172512A1 Interaction of t-cell receptors and antigen in autoimmune disease
03/30/1995CA2172494A1 Use of angiotensin ii analogs in tissue repair
03/30/1995CA2172491A1 Method for the treatment or prevention of eczema/dermatitis
03/30/1995CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995CA2172385A1 Nucleic acids encoding merosin, merosin fragments and uses thereof
03/30/1995CA2172287A1 Nf-at polypeptides and polynucleotides
03/30/1995CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/30/1995CA2169620A1 Retargeting antibodies
03/30/1995CA2149783A1 Novel peptides
03/30/1995CA2148354A1 Methods for enhancing vascularization of implant devices
03/29/1995EP0645452A1 Human interferon-beta 2A and interfeon-beta 2B, vectors containing genes coding for said interferons, cell lines producing same and use of said interferons as pharmaceuticals
03/29/1995EP0645451A1 Heparin binding site structural analogues of fibroblast growth factors
1 ... 2853 2854 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 ... 3163